Revolution Medicines presented clinical trial success for daraxonrasib, a novel targeted cancer therapy, at the American Association of Cancer Research annual meeting.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Revolution Medicines previews 'novel class' of cancer treatments | STAT
Daraxonrasib Drug name
Advanced Pancreatic Cancer Cancer type targeted
Next-Generation Targeted Therapy Therapy classification